Ji Yao Holding Group Co., Ltd. Stock

Equities

300108

CNE100000ST7

Pharmaceuticals

End-of-day quote Shenzhen S.E. 06:00:00 2024-04-23 pm EDT 5-day change 1st Jan Change
1.72 CNY -1.71% Intraday chart for Ji Yao Holding Group Co., Ltd. -6.52% -47.08%
Sales 2021 685M 94.5M Sales 2022 489M 67.48M Capitalization 1.29B 178M
Net income 2021 -451M -62.24M Net income 2022 -276M -38.09M EV / Sales 2021 7.19 x
Net Debt 2021 2.04B 282M Net Debt 2022 1.65B 227M EV / Sales 2022 6.01 x
P/E ratio 2021
-6.39 x
P/E ratio 2022
-4.69 x
Employees 1,123
Yield 2021 *
-
Yield 2022
-
Free-Float 20.51%
More Fundamentals * Assessed data
Dynamic Chart
Sihuan Pharmaceutical Holdings Unit Forms Consortium for Ji Yao Restructuring MT
A consortium of unknown buyers acquired 9.68% stake in Ji Yao Holding Group Co., Ltd. from Lu Zhongkui. CI
Chen Xinkai, Lu Meng, Dai Xuya, and Quan Hui He Ke agreed to acquire 3.75% stake in Ji Yao Holding Group Co., Ltd. from Lu Zhongkui?s for CNY 77.14 million. CI
Shaanxi Yuehetang Pharmaceutical Co., Ltd. completed the acquisition of Jiangsu Puhua Kesheng Pharmaceutical Co., Ltd. from Ji Yao Holding Group Co., Ltd.. CI
Shaanxi Yuehetang Pharmaceutical Co., Ltd. agreed to acquire Jiangsu Puhua Kesheng Pharmaceutical Co., Ltd. from Ji Yao Holding Group Co., Ltd. for CNY 62 million. CI
Ji Yao Holding Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Ji Yao Holding Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Ji Yao Holding Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Ji Yao Holding Group Co., Ltd. Auditor Raises 'Going Concern' Doubt CI
Ji Yao Holding Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Tontine Wines Establishes Herbal Wine Subsidiary MT
Zhu Yuyong completed the acquisition of 48% of stake in Jilin Jinbao Pharmaceutical Co., Ltd.. CI
Chinese Securities Regulator Slaps Ji Yao Holding With 2 Million Yuan Fine Over Disclosure Breaches MT
Zhu Yuyong agreed to acquire 48% of stake in Jilin Jinbao Pharmaceutical Co., Ltd. for CNY 24 million. CI
Ji Yao Holding Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022 CI
More news
1 day-1.71%
1 week-6.52%
Current month-22.17%
1 month-28.03%
3 months-46.42%
6 months-53.39%
Current year-47.08%
More quotes
1 week
1.53
Extreme 1.53
1.84
1 month
1.53
Extreme 1.53
2.37
Current year
1.53
Extreme 1.53
3.45
1 year
1.53
Extreme 1.53
4.07
3 years
1.44
Extreme 1.44
5.58
5 years
1.44
Extreme 1.44
8.49
10 years
1.44
Extreme 1.44
17.47
More quotes
Managers TitleAgeSince
Chief Executive Officer 34 22-06-07
Director of Finance/CFO 46 17-10-12
Chief Tech/Sci/R&D Officer 85 07-12-15
Members of the board TitleAgeSince
Director/Board Member 53 22-06-07
Director/Board Member 36 22-06-07
Corporate Officer/Principal 66 07-12-15
More insiders
Date Price Change Volume
24-04-24 1.72 -1.71% 9,800,999
24-04-23 1.75 -0.57% 15,342,300
24-04-22 1.76 +13.55% 23,980,450
24-04-19 1.55 -9.88% 22,913,980
24-04-18 1.72 -6.52% 14,559,300

End-of-day quote Shenzhen S.E., April 23, 2024

More quotes
Ji Yao Holding Group Co., Ltd., formerly Tong Hua Shuang Long Chemical Industry Co., LTD., is a China-based company principally engaged in the research, development, production and sales of drugs. The Company's main products include Zhitong Huazheng Jiaonang (analgesic capsules), Reduping Keli (granules for cold) and Tongluo Zhitong medicinal liquor. The Company is also involved in the production, manufacture and sale of fine chemicals. The Company distributes its products in the domestic market.
Calendar
More about the company
  1. Stock Market
  2. Equities
  3. 300108 Stock